MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
504.23%
Quick Ratio
393.93%
Cash Ratio
168.73%
Debt to Asset Ratio
45.98%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Inventories, net
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Long-term debt, net
    • Treasury stock, at cost, inclusi...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
205,875
144,306
158,545
147,589
Short-term available-for-sale investments
45,156
57,874
79,879
98,745
Accounts receivable, net
132,420
125,635
124,069
115,268
Inventories, net
134,575
150,370
152,863
157,680
Assets held for sale
67,337
-
-
-
Prepaid expenses and other current assets
29,852
36,776
32,618
43,469
Total current assets
615,215
514,961
547,974
562,751
Fixed assets, net
130,277
136,281
140,690
147,388
Right-of-use assets, net
44,920
39,409
41,777
44,266
Goodwill
19,642
19,773
20,214
20,317
Intangible assets, net
285,484
353,227
368,100
382,396
Deferred tax assets
124,598
122,115
123,854
120,188
Investments and other assets
23,842
22,768
22,308
20,271
Total assets
1,243,978
1,208,534
1,264,917
1,297,577
Accounts payable
17,509
14,012
15,150
17,687
Accrued expenses
93,499
84,957
95,601
79,643
Lease liabilities
10,298
9,818
9,839
9,748
Current portion of long-term debt, net
-
-
0
0
Liabilities held for sale
705
-
-
-
Total current liabilities
122,011
108,787
120,590
107,078
Long-term debt, net
363,124
367,656
372,189
376,721
Lease liabilities
38,695
33,705
36,176
38,839
Contingent consideration
17,452
15,789
18,066
17,834
Deferred tax liabilities
4,070
4,093
4,213
4,587
Other liabilities
26,650
24,611
20,572
25,304
Total liabilities
572,002
554,641
571,806
570,363
Common stock, par value 0.001 250,000,000 shares authorized 48,840,889 shares issued and 39,822,298 shares outstanding at june30, 2026 and 47,890,777 shares issued and 41,116,739 shares outstanding at december31, 2025
49
48
48
48
Treasury stock, at cost, inclusive of excise tax and broker fees, 9,018,591 and 6,774,038 shares at june30, 2026 and december31, 2025, respectively
227,013
227,013
176,565
125,543
Additional paid-in capital
1,087,452
1,073,809
1,064,623
1,049,545
Accumulated deficit
-191,753
-196,406
-199,322
-200,959
Accumulated other comprehensive income
3,241
3,455
4,327
4,123
Total stockholders equity
671,976
653,893
693,111
727,214
Total liabilities and stockholders equity
1,243,978
1,208,534
1,264,917
1,297,577
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$205,875K (-31.49%↓ Y/Y)Inventories, net$134,575K (-9.17%↓ Y/Y)Accounts receivable, net$132,420K (15.79%↑ Y/Y)Assets held for sale$67,337K Short-termavailable-for-sale investments$45,156K (-68.94%↓ Y/Y)Prepaid expenses andother current assets$29,852K (-19.79%↓ Y/Y)Total current assets$615,215K (-17.49%↓ Y/Y)Intangible assets, net$285,484K (-32.44%↓ Y/Y)Fixed assets, net$130,277K (-16.05%↓ Y/Y)Deferred tax assets$124,598K (-2.86%↓ Y/Y)Right-of-use assets, net$44,920K (-3.46%↓ Y/Y)Investments and other assets$23,842K (26.75%↑ Y/Y)Goodwill$19,642K (-3.24%↓ Y/Y)Total assets$1,243,978K (-19.08%↓ Y/Y)Total liabilities andstockholders equity$1,243,978K (-19.08%↓ Y/Y)Total stockholdersequity$671,976K (-11.32%↓ Y/Y)Total liabilities$572,002K (-26.62%↓ Y/Y)Treasury stock, at cost,inclusive of excise tax and...$227,013K (200.62%↑ Y/Y)Accumulated deficit-$191,753K (7.09%↑ Y/Y)Additional paid-in capital$1,087,452K (5.01%↑ Y/Y)Long-term debt, net$363,124K (271.19%↑ Y/Y)Total currentliabilities$122,011K (-61.04%↓ Y/Y)Lease liabilities$38,695K (-6.29%↓ Y/Y)Other liabilities$26,650K (5.95%↑ Y/Y)Contingent consideration$17,452K (1.41%↑ Y/Y)Deferred tax liabilities$4,070K (-11.19%↓ Y/Y)Accumulated othercomprehensive income$3,241K (-20.21%↓ Y/Y)Common stock, par value0.001 250,000,000...$49K (2.08%↑ Y/Y)Accrued expenses$93,499K (31.65%↑ Y/Y)Accounts payable$17,509K (-41.88%↓ Y/Y)Lease liabilities$10,298K (7.05%↑ Y/Y)Liabilities held for sale$705K

Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences, Inc. (PCRX)